
Metcela
Developing regenerative medicine solutions using stem cell technology.
About
Metcela is a clinical-stage biotechnology company focused on developing regenerative cell therapies for chronic diseases, particularly cardiovascular conditions like heart failure. Their lead asset, MTC001, utilizes autologous cardiac fibroblasts to repair damaged heart tissue, with a proprietary delivery system for precise administration. They also acquired Japan Regenerative Medicine Co., Ltd., which develops cardiac stem cell-based therapy for pediatric congenital heart diseases.
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Metcela?
People comparing tools land here. Get listed beside these.
All funding rounds
Key facts
- Website
- metcela.com
- Headquarters
- Tokyo, Japan
- Founded
- 2012
- Founders
- Takahiro Iwamiya, Kenichi Nogami
- Total funding
- $36M (Series C)
- Business model
- B2B
Funding rounds
- $14M29 Jun 2022Series CLargest round
- $13M5 Jan 2021
- $4M1 Apr 2020
- $5M1 Sept 2018
- $630K1 Jun 2016
Tech stack
Detected on metcela.com, last scanned 3 Sept 2026. Run your own scan
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Benchmarking
See how your site ranks against 16,849 startups
Metcela sits in the 49th percentile for Domain Rating. Check where yours lands, free.
Check your Domain RatingMetcela has a Domain Rating of 40, the 49th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Below median
Check yoursAgent Readiness
Top 25%
Scan yoursSite Speed
Bottom 25%
PageSpeedData Trust
Above median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Metcela scores 51. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentAI visibility
Get read by ChatGPT, Claude and Perplexity
List your startup, then track where you show up in AI answers.
AI reads of this profile
Last 14 days, from server logs
Get notified when Metcela changes
Used Metcela? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Who owns Metcela?
Metcela is privately held, owned by its founders and investors. Sony Innovation Fund has backed 3 of the 5 rounds on record since September 2018, ahead of Dai-ichi Life Insurance Company (2), so it is likely among the largest outside shareholders. Exact stakes are not public.
Is Metcela trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Metcela is 64 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Metcela raised?
Metcela has raised a total of $36M in funding. The most recent round on record is Series C.
SEC filings, insider activity, nonprofit links and pay benchmarks for Metcela:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Metcela and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


